Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

BGM0504

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

BrightGene Bio-Medical Technology Co · Phase 1 · Completed · Enrollment 80

NCT07166081

ArmPopulationDoseWeeksEstimandWeight change
Cohort 1Obesity or overweightn/rn/rn/rn/r
Cohort 2Obesity or overweightn/rn/rn/rn/r
Cohort 3Obesity or overweightn/rn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r
Cohort 4Obesity or overweightn/rn/rn/rn/r